ArticleBMC nephrology2024

18-month longitudinal SARS COV-2 neutralizing antibody dynamics in haemodialysis patients receiving heterologous 3-dose vaccination (AZD-1222- AZD-1222- BNT162b2) in a lower middle income setting.

Ridma Prasadini Karunathilake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.